Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457521 · ClinicalTrials.gov registry record · Phase 4
Pain Control In First Trimester Medical Abortion: A Randomized Trial
A Phase 4 study of Pain, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT01457521: Completed Phase 4 study of Pain, sponsored by Gynuity Health Projects.
NCT01457521 is a Phase 4 study of Pain that has completed, run by Gynuity Health Projects. The registered enrollment target is 250 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457521, a Phase 4 study of Pain, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.
Primary Outcome
Participant pain was assessed using an 11-point Visual Analog Scale for Pain. Scores ranged from 0 (no pain) to 10 (worst pain possible)
Conditions Studied
Interventions
- DRUG Ibuprofen
Study Locations (2)
Illinois
- Family Planning Associates Medical Group - Chicago
New York
- Planned Parenthood of New York City, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
What the finished NCT01457521 record still lists
NCT01457521 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Ibuprofen is the first listed.
NCT01457521 reports a single indexed study location in Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT01457521 about?
NCT01457521 is a clinical study titled "Pain Control In First Trimester Medical Abortion: A Randomized Trial". This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.
What is the current status of trial NCT01457521?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2011-10. Estimated completion is 2012-12.
What conditions does trial NCT01457521 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01457521?
The interventions under investigation include: Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01457521?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457521 being conducted?
This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01457521's enrollment target sits among peer trials
250 70th of 374 higher than 303 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia